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Abstract
Alginate overproduction, or mucoidy, plays an important role in the pathogenesis of P. aeruginosa lung infection in cystic
fibrosis (CF). Mucoid strains with mucA mutations predominantly populate in chronically-infected patients. However, the
mucoid strains can revert to nonmucoidy in vitro through suppressor mutations. We screened a mariner transposon library
using CF149, a non-mucoid clinical isolate with a misssense mutation in algU (AlgUA61V). The wild type AlgU is a stress-
related sigma factor that activates transcription of alginate biosynthesis. Three mucoid mutants were identified with
transposon insertions that caused 1) an overexpression of AlgUA61V, 2) an overexpression of the stringent starvation protein
A (SspA), and 3) a reduced expression of the major sigma factor RpoD (s70). Induction of AlgUA61V in trans caused
conversion to mucoidy in CF149 and PAO1DalgU, suggesting that AlgUA61V is functional in activating alginate production.
Furthermore, the level of AlgUA61V was increased in all three mutants relative to CF149. However, compared to the wild type
AlgU, AlgUA61V had a reduced activity in promoting alginate production in PAO1DalgU. SspA and three other anti-s70
orthologues, P. aeruginosa AlgQ, E. coli Rsd, and T4 phage AsiA, all induced mucoidy, suggesting that reducing activity of
RpoD is linked to mucoid conversion in CF149. Conversely, RpoD overexpression resulted in suppression of mucoidy in all
mucoid strains tested, indicating that sigma factor competition can regulate mucoidy. Additionally, an RpoD-dependent
promoter (PssrA) was more active in non-mucoid strains than in isogenic mucoid variants. Altogether, our results indicate
that the anti-s70 factors can induce conversion to mucoidy in P. aeruginosa CF149 with algU-suppressor mutation via
modulation of RpoD.
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Introduction
The Gram-negative bacterium P. aeruginosa is an important
opportunistic pathogen in humans, and has the potential to
proliferate in a wide range of niches. P. aeruginosa is one of the
major etiological agents of hospital-acquired infections and
ventilator-associated pneumonia [1]. More importantly, P. aerugi-
nosa is the leading cause of morbidity and mortality in cystic
fibrosis (CF) patients [2].
P. aeruginosa can produce a capsule-like polysaccharide called
alginate. Overproduction of alginate is also known as mucoidy [3].
Mucoid conversion facilitates the establishment of persistent
infection with P. aeruginosa in CF. The role of alginate in
pathogenesis includes: increased resistance to antibiotics [2],
increased resistance to phagocytic killing [4,5] and evasion of
the host’s immune response [4]. However, the mucoid phenotype
observed in CF isolates is extremely unstable ex vivo [6,7,8].
Reversion to non-mucoidy is common in vitro in the absence of a
selective pressure, and in vivo during the end-stage of CF disease
[9]. Although, environmental signals such as high osmolarity,
nitrogen or phosphate starvation, and ethanol-induced membrane
perturbation can activate transcription of algD encoding the key
enzyme for alginate biosynthesis [10], the selective pressure for
mucoid conversion of P. aeruginosa in CF respiratory environment
is not fully understood.
Several genes in P. aeruginosa are known to regulate alginate
production. Specifically, AlgU (AlgT, s22) is an alternative sigma
factor that drives the transcription of algD [11]; MucA is a trans-
membrane protein that negatively regulates alginate production by
sequestering AlgU [12]; MucB and proteases AlgW, MucP and
ClpXP affect alginate production by altering the stability of MucA
[13]. Mutations in mucA are recognized as the primary reason for
mucoid conversion in CF isolates [14,15,16,17]. However, the
reversion from a mucoid to a non-mucoid phenotype is still
possible. Sautter et al. isolated 34 spontaneous non-mucoid
variants from a MucA truncated mucoid stain PDO300 [18]. In
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another study, 70% of the non-mucoid CF isolates carried a mucA
mutation [19].
The aim of this study was to better understand the alginate
regulation by determining if there are upstream mutations that
restore alginate overproduction to a clinical nonmucoid, algU mucA
double mutant (CF149). To achieve this objective, we conjugated
the mariner transposon plasmid pFAC [20] into the mucA mutant
CF149 with an alginate-suppressing mutation [21], and screened
for mucoid variants. Three genes were identified that regulated
mucoidy in CF149. Mechanistic studies suggest that mucoid
conversion in MucA truncated strains including CF149, is related
to competition between the two sigma factors, the major house
keeping sigma factor RpoD and AlgU for binding to the core RNA
polymerase (RNAP). Additionally, we documented that anti-s70
factors have the ability to induce mucoidy in the suppressed non-
mucoid P. aeruginosa strain CF149.
Materials and Methods
Bacteria Strains, Plasmids, and Growth Conditions
Bacterial strains and plasmids used in this study are shown in
Table S1. Escherichia coli strains were grown at 37uC in Lennox
broth (LB) or LB agar. P. aeruginosa strains were grown at 37uC in
LB or on Pseudomonas isolation agar (PIA) plates (Difco). When
required, carbenicillin, tetracycline or gentamicin were added to
the broth or plates. The concentrations of carbenicillin, tetracy-
cline or gentamicin added in LB broth or plates were 100 mg ml21,
20 mg ml21 and 15 mg ml21, respectively. The concentration of
these antibiotics added to PIA plates were 300 mg ml21, 150 mg
ml21 or 300 mg ml21, respectively.
Figure 1. Increased alginate production in three mutants of CF149 with an algU-suppressor mutation. (A) Schematic diagram showing
the transposon insertions of CF149 (+algU), CF149 (+sspA), and CF149 (2rpoD), respectively. (B) Alginate production of CF149 (+algU), CF149 (+sspA),
and CF149 (2rpoD) in comparison to other strains of P. aeruginosa. Three mucoid mutants were identified as a result of a transposon library screen.
Alginate production was measured on PIA plates after incubation at 37uC for 24 hrs. Alginate production (mg/ml/OD600) was measured as described
in Materials and Methods. M and NM, represent mucoidy and nonmucoidy, respectively.
doi:10.1371/journal.pone.0072329.g001
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Phage Culture and Genomic DNA Extraction
E. coli BB was inoculated into 6 ml LB, and incubated at 37uC
with shaking. At an OD600 of 0.6, 200 ml of T4 phage stock was
added to the culture, and incubated overnight. Phage lysates were
collected using a 0.2 mm filter. Phage genomic DNA was extracted
using the standard procedure with phenol:chloroform:isoamyl
alcohol, and precipitated with ethanol.
Transformation and Conjugation
The One ShotH TOP10 (Invitrogen) chemical transformation
method was used according to the supplier’s instruction. The
transfer of plasmids from E. coli to Pseudomonas was performed via
triparental conjugations using the helper plasmid pRK2013 [22].
Transposon Mutagenesis
Biparental conjugations were carried out for transposon
mutagenesis, using E. coli SM10 lpir carrying plasmid pFAC as
the donor strain [20] and CF149 as the recipient strain. After
incubation, bacteria were collected and streaked onto PIA plates
supplemented with gentamicin (300 mg ml21). Mucoid colonies
were identified and subjected to further genetic analyses. The
chromosomal DNA of mucoid mutants was isolated using the
QIAamp genomic DNA Extraction kit (Qiagen). Approximately,
2 mg DNA was digested with SalI overnight at 37uC followed by
purification and self-ligation using Fast-Link DNA ligase (Epicen-
tre). The circular closed DNA was used as template for inverse
PCR using GM3OUT and GM5OUT primers [23]. The PCR
products were purified and sequenced. Finally, southern blot
hybridization was used to monitor the copy number of transposon
insertions using the GmR gene as the probe [24].
Protein Preparation, SDS-PAGE and Western Blotting
Bacteria were cultured on PIA plates for 24 hrs and then
collected for cell lysis. Following sonication, the protein concen-
tration of the resulting supernatant was measured using the Bio-
Rad Dc protein assay reagents (Bio-Rad). Equal amounts protein
were mixed with 26sample loading buffer and separated on a pre-
cast SDS-PAGE gels (Bio-Rad); Total proteins were transferred to
PVDF membrane (GE) for immuno-detection. A primary
monoclonal antibody of rat anti-HA (Roche) was used at a
dilution of 1:5000, while a goat anti-rat immunoglobulin G (heavy
and light chains) conjugated with horseradish peroxidase (Pierce)
(1:5000) was used as the secondary antibody. The immunoreactive
proteins were visualized using the Amersham ECL kit (GE).
Alginate Assay
P. aeruginosa strains were grown at 37uC on triplicate PIA plates
for 24 hrs. The bacteria were collected and suspended in PBS.
The OD600 of bacterial suspension in PBS, which corresponds to
the bacterial density, was measured. The amount of uronic acid
was analyzed in comparison with a standard curve made with D-
mannuronic acid lactone (Sigma-Aldrich), as previously described
[25].
b-galactosidase Activity Assay
Pseudomonas strains carrying the plasmid pLP170 containing the
PssrA, PalgD and PalgW promoters fused with the promoterless lacZ
were cultured on three PIA plates. After 24 hrs, bacterial cells
were harvested and re-suspended in PBS. OD600 was measured
and adjusted to approximately 0.3. Cells were then permeabilized
using toluene, and the b-galactosidase activity was measured at
OD420 and OD550. The results of Miller Units were calculated
according to this formula: Miller Units = 10006[OD420–
(1.756OD550)]/[Reaction time (minutes)6Volume (ml)6OD600]
[26]. The reported values represent an average of three
independent experiments with standard error.
RNA Isolation and Real-time PCR
Bacteria total RNA were extracted with a RNeasy Mini Kit
(QIAGEN, USA) according to the manufacturer’s instructions.
The real-time PCR assays were performed on ABI PRISMH 7000
(ABI, USA) with One Step SYBRH PrimeScriptTM RT-PCR KIT
II (TaKaRa, Japan) according to the manufacturer’s instructions.
The rpoD gene was amplified using primers rpoD-RT-F (59-AGA
AGG ACG ACG AGG AAG A-39) and rpoD-RT-R (59-GCA
CCA GCT TGA TCG GCA TGA -39). The 16S rRNA gene was
amplified using primers UniF340 (59-ACT CCT ACG GGG
AGG CAG CAG T-39) and UniR514 (59-ATT ACC GCG GCT
GCT GGC-39) [27]. The relative expression level of rpoD was
Figure 2. Over-expression of SspA induces mucoidy in CF149.
The sspA and sspB genes from P. aeruginosa were cloned behind the
PBAD promoter in the pHERD20T vector, and conjugated into CF149. (A)
Western blot analysis of SspA and SspB proteins using an anti-HA
monoclonal antibody. Lanes 1, 2 and 3 represent total cellular proteins
extracted from CF149 carrying pHERD20T-sspA, pHERD20T-sspB, and
pHERD20T, respectively. (B) Morphology of CF149 containing
pHERD20T-sspA, pHERD20T-sspB and pHERD20T. These strains were
streaked on PIA plates supplemented with 300 mg/ml of carbenicillin,
0.1% L-Ara and incubated overnight at 37uC. Alginate production (mg/
ml/OD600) was measured as described in Materials and Methods.
doi:10.1371/journal.pone.0072329.g002
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normalized to 16S rRNA, and calculated according to the
formula: fold change= 22DDct [28].
Measurement of Bacterial Growth
The Pseudomonas strains were grown in LB culture medium
overnight at 37uC, then diluted to OD600 = 0.5 using PBS. Then
1 ml bacteria suspension was inoculated into a 250 ml flask
containing 50 ml Pseudomonas Isolation Broth (PIB; Alpha Biosci-
ences). To measure bacterial growth, OD600 was monitored every
2 hrs for 24 hrs. Triplicate of samples at each time point were
measured, and the means with standard error were used to
generate the growth curve.
Statistical Analysis
The student t test and one-way ANOVA were performed using
the statistical software SPSS 13.0 (IBM, US) with P,0.05
considered as significant.
Results
Identification of Alginate Regulators in a P. aeruginosa
Strain with a Suppressor Mutation
CF149 is a clinical isolate from a patient with CF [24]. CF149
displays a nonmucoid phenotype on PIA and PIA plus ammonium
metavanadate (PIA-AMV) plates [29]. Previously, we reported
CF149 have two mutations resulting in abrogation of an AlgU-
dependent transcription of lipotoxin LptF [21]. First, a frameshift
Table 1. The effect of anti-s70 factors on mucoid induction in strains of P. aeruginosa.
Strains MucA length AlgU length rsd (TOP 10) algQ b (PAO1) sspA (PAO1) asiA (T4 phage)
CF149 125+3 aa a Ala61Val (193 aa) M (29.0462.44) M (28.3362.74) M (51.2860.85) M (54.5162.28)
CF4349 125+3 aa WT (193 aa) NM (2.3560.18) NM (9.4961.26) NM (8.5362.06) NM (5.6062.07)
CF28 117 aa Tyr29Cys (193 aa) (193aa) NM (6.3762.51) NM (8.1062.79) NM (13.2060.72)
(13.2060.72)
(13.2060.72)
NM (11.5662.05)
CF17 143+3 aa WT (193 aa) NM (11.4562.97) NM (13.5262.64 NM (10.5760.75) NM (7.9460.72)
FRD2 143+3 aa Asp18Gly (193 aa) NM (14.0860.21) NM (11.7461.53) NM (7.0560.03) NM (14.6460.94)
PAO1 WT (194 aa) WT (193 aa) NM (14.4861.56) NM (7.8461.67) NM (9.3860.3) NM (17.7661.46)
PA14 WT (194 aa) WT (193 aa) NM (9.6361.25) NM (8.9561.15) NM (8.7560.24) NM (14.4762.59)
CF3715 WT (194 aa) WT (193 aa) NM (13.0563.60) NM (6.1060.67) NM (6.2060.19) NM (15.5961.28)
CF4009 WT (194 aa) WT (193 aa) NM (9.2160.49) NM (7.2462.31) NM (8.6960.11) NM (15.6462.52)
M and NM represent a mucoid and a non-mucoid phenotype, respectively, after incubation on PIA plates supplemented with 300 mg/ml of carbenicillin and 0.1% L-Ara
at 37uC for 24 hrs. The quantity of alginate production was measured (mean 6 standard error, mg/ml/OD600) and listed in the brackets.
athe frameshift mutation in mucA results in the fusion of a truncated MucA (125 amino acids of N-terminal MucA) with an additional 3 amino acids with no homology to
the amino acid sequence of wild type MucA.
ba concentration of 0.5% L-Ara was needed to induce the conversion to mucoidy in CF149. The alginate production of all AlgQ-overexpressing strains was measured on
PIA plates containing 300 mg/ml of carbenicillin and 0.5% L-Ara.
doi:10.1371/journal.pone.0072329.t001
Table 2. Over-expression of RpoD suppresses mucoidy in laboratory and clinical strains of P. aeruginosa.
Strains
Alginate production
(mg/ml/OD600) MucA length AlgU length Alginate regulator
PHERD 20T-
HA-rpoD-His
Laboratory strains PAO1-VE2 M (64.8066.52) WT (194 aa) WT (193 aa) Over-expression of MucE NMa
PAO1-VE13 M (20.9361.05) WT (194 aa) WT (193 aa) Inactivation of KinB NM
PAO1-VE19 M (61.2362.90) WT (194 aa) WT (193 aa) Inactivation of MucD NMa
PAO581 M (58.9563.07) 59 aa+35 aa WT (193 aa) MucA25 NMa
PAO579 M (48.0460.11) WT (194 aa) WT (193 aa) PilA108 NMa
Clinical strains CF149 (2rpoD) M (30.1660.61) 125+3 aa Ala61Val Reduced-expression of rpoD NM
CF149 (+algU) M (44.2060.49) 125+3 aa Ala61Val Over-expression of algU NMa
CF149 (+sspA) M (25.4061.07) 125+3 aa Ala61Val Over-expression of sspA NM
FRD1 M (56.2764.06) 143+3 aa WT MucA22 NM
PDO300 M (68.0861.25) 143+3 aa WT MucA22 NM
CF1003M M (30.6162.28) 59 aa+35 aa WT (193 aa) Unknown NM
CF7447M M (20.2261.40) WT (194 aa) WT (193 aa) Unknown NM
NM and M represent non-mucoidy and mucoidy, respectively, after incubation on PIA plates supplemented with 300 mg/ml of carbenicillin and 0.1% L-Ara at 37uC for
24 hrs.
aa concentration of 0.5% L-Ara was needed to completely suppress mucoidy. The values for alginate production represent an average of three independent
experiments with standard error.
doi:10.1371/journal.pone.0072329.t002
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Figure 3. Alginate induction by CF149 AlgUA61V, the detection of AlgUA61V and the promoter activity of PalgD-lacZ in CF149 (+algU),
CF149 (+sspA) and CF149 (2rpoD). (A) AlgUA61V retained the function of inducing alginate production. The wild type algU gene of PAO1 and its
variant of CF149 were cloned into pHERD20T, and conjugated into PAO1DalgU. Strains containing pHERD20T-algUWT (PAO1), pHERD20T-algUA61V
(CF149), and pHERD20T were streaked on PIA plates supplemented with 300 mg/ml of carbenicillin and incubated overnight at 37uC. Alginate
production (mg/ml/OD600) was measured as described in Materials and Methods. (B) The level of AlgU in CF149, CF149 (+algU), CF149 (2rpoD) and
CF149 (+sspA) was detected using Western blot with anti-AlgU monoclonal antibody [16]. (C) Measurement of the activity of the algD promoter in the
respective strains. The PalgD promoter was inserted into pLP170 vector containing the promoterless lacZ gene. The pLP170 PalgD-lacZ was transferred
into the respective strains via triparental conjugation. The b-galactosidase activity was measured as described in Materials and Methods. *, represents
a significant difference compared to CF149 (P,0.05).
doi:10.1371/journal.pone.0072329.g003
Alginate Regulation by Anti-s70 Factors
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mutation in mucA is predicted to produce a truncated MucA
protein with 128 amino acids in contrast to wild type MucA with
194 amino acids. Second, CF149 carries a missense mutation in
algU predicted to result in a substitution of alanine for valine at
position 61 of the primary amino acid sequence of AlgU
(AlgUA61V) [21]. To determine whether the alginate suppressor
strain CF149 still had the ability to restore mucoidy, a transposon
library was constructed and screened. As seen in Figure 1A, we
identified three insertions that promote alginate production [17].
Southern blot analysis showed that only one copy of the
transposon was inserted on the chromosome in these mucoid
strains (data not shown). We mapped the insertion site using
inverse PCR as previously described [17,23]. Two insertions were
identified in intergenic regions between PA0762 (algU) and
PA0761 (nadB), and PA4428 (sspA) and PA4429 (probable
cytochrome c1 precursor) (Figure 1A). In these two mutants, the
transposon was upstream of algU and sspA, and was oriented in the
same direction as the previously-observed insertion causing an
overexpression of mucE [17]. These two mutants likely had an
overexpression of algU and sspA from read through of the
gentamicin-resistance gene (aacC1) promoter (PGm) [30]. These
strains were named CF149 (+algU) and CF149 (+sspA). The third
mutant had an insertion site of 78 base pairs behind the stop
codon of the rpoD gene (Figure 1A). The rpoD gene (PA0576)
encodes the major housekeeping sigma factor (s70). RpoD is
essential for the growth and viability of cells, and no rpoD mutant
has been reported in the P. aeruginosa mutant bank [31]. Because
the orientation of the pFAC PGm is opposite to the direction of
rpoD gene, the insertion is predicted to reduce the expression of
rpoD. This strain was named CF149 (2rpoD). To verify the
decreased transcription of rpoD in CF149 (2rpoD), we compared
the transcript level by real-time PCR, and the activity of an RpoD-
dependent promoter PssrA-lacZ in two isogenic strains. The results
showed that the transcript level of rpoD in CF149 (2rpoD) was 60%
of the value of CF149. The Miller assay results also showed that
the PssrA-lacZ activity reduced by 68% in CF149 (2rpoD) compared
to CF149. The alginate production by these mucoid strains was
also measured and shown to be more than 2-fold higher than the
parent strain (Figure 1B).
SspA, not SspB, Induces Mucoidy in CF149
The operon of sspAB encodes the stringent starvation proteins A
and B that function in response to amino acid starvation [32]. The
sspA and sspB genes share the same promoter, and are co-
expressed in E. coli [32]. SspB is also a specificity-enhancing factor
for the protease ClpXP in E. coli [33]. ClpXP has been reported to
regulate alginate production in P. aeruginosa [23]. In order to
determine which gene is responsible for the mucoid conversion in
CF149 (+sspA), P. aeruginosa sspA and sspB were cloned behind the
PBAD promoter in the shuttle vector pHERD20T [34]. As seen in
Figure 2A, we detected the expression of SspA and SspB in CF149
after induction with 0.1% L-arabinose (L-Ara). However, we
observed a mucoid phenotype only with the overexpression of sspA
(Figure 2B), indicating that SspA is an inducer of alginate
production when overexpressed in CF149.
Anti-s70 Factors Induce Conversion to Mucoidy in CF149
The mucoid phenotype expressed by CF149 (+sspA) and CF149
(2rpoD) suggests that RpoD may be involved in the alginate
regulation. Schlictman et al. reported that E. coli sspA can
complement the algQ mutation by restoring mucoidy in a CF
clinical isolate [35]. AlgQ and Rsd belong to the family of the
regulators of the major sigma factor RpoD (s70) in Proteobacteria.
Members of the anti-s70 factors are thought to interact with the
conserved region 4 of s70 subunit of RNAP [36]. Similarly, AsiA,
encoded in the T4 phage, also functions as an anti-s70 factor [37].
Figure 4. The effect of mucA on the mucoid suppression in CF149 (+algU), CF149 (+sspA) and CF149 (2rpoD). AlgUA61V–induced
mucoidy was suppressed by the wild type mucA in trans. The mucA gene was over-expressed in trans in CF149(+algU), CF149(2rpoD) and
CF149(+sspA) by adding 0.1% L-Ara in PIA supplemented with 300 mg/ml carbenicllin. The plate was incubated for 24 hrs at 37uC.
doi:10.1371/journal.pone.0072329.g004
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Our hypothesis is that CF149 (+sspA) and CF149 (2rpoD) utilize
the mechanism of modulating RpoD to become mucoid. To test
this, we cloned the rsd gene from E.coli, algQ and sspA from P.
aeruginosa, and asiA from T4 phage in pHERD20T. As seen in
Table 1, overexpression of these genes caused conversion to
mucoidy in CF149. However, the anti-s70 factors had no effect on
mucoid induction in other strains tested, even though CF4349 has
a wild type algU and the same predicted length of MucA as CF149
(Table 1). However, mucoidy of CF149 (+sspA) could be due to a
non-specific effect. To test this possibility, we examined the effect
of anti-RpoF factor FlgM on mucoid conversion. As seen in Figure
S1, FlgM had no effect on mucoid induction in PAO1 and CF149.
Overexpression of rpoD Results in Suppression of
Mucoidy
Mucoidy in CF149(2rpoD), CF149(+sspA) and CF149(+algU )
could be due to the competition between RpoD and AlgU for
RNAP. To test this hypothesis, rpoD was cloned and overexpressed
in various mucoid strains. The mucoid laboratory and clinical
isolates were all suppressed by the overexpression of RpoD
(Table 2). However PAO1-VE2, PAO1-VE19, PAO579 and
PAO581 required a higher concentration of L-ara (0.5% vs. 0.1%)
for a complete suppression of mucoidy (Table 2). To further test
the hypothesis that sigma factor competition can reduce the
activity of AlgU resulting in the suppression of alginate production,
we induced RpoN (s54), RpoS(s38), and RpoF(s28) in various
Figure 5. Regulation of RpoD- and AlgU-dependent promoters in isogenic non-mucoid and mucoid strains of P. aeruginosa. (A) The b-
galactosidase activity of AlgU-dependent promoter PalgD-lacZ and alginate production (mg/ml/OD600) were measured in non-mucoid and mucoid
strains. (B) The b-galactosidase activity of an RpoD-dependent promoter PssrA-lacZ was measured in non-mucoid and mucoid strains. *, represents a
significant difference compared to PAO1 (P,0.05).
doi:10.1371/journal.pone.0072329.g005
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mucoid mutants. As expected, overexpression of these sigma
factors suppressed alginate production (Table S2). We also
observed that overexpressed RpoD was unstable in P. aeruginosa
and E.coli (Figure S2).
Missense Mutation in CF149 algU Results in Production
of a Variant of AlgU with Reduced Function
One explanation for mucoidy in CF149 (+algU) is that AlgUA61V
retains some function despite the amino acid substitution. To test
this, we compared the function of AlgUA61V vs. wild type AlgU by
measuring the amount of alginate induced by two forms of AlgU
in the PAO1DalgU strain. CF149 AlgUA61V kept the ability to
induce mucoidy, albeit with a reduced amount of alginate
(Figure 3A). To explain how the three mutants become mucoid,
we next measured the level of AlgUA61V in the total cell lysates of
CF149 (+algU), CF149 (2rpoD) and CF149 (+sspA) through
Western blot. The AlgU protein level was increased in CF149
(+algU), CF149 (2rpoD) and CF149 (+sspA) compared to the parent
CF149 (Figure 3B). The promoter activity of PalgD-lacZ also
increased in these mucoid strains (Figure 3C).We also tested the
hypothesis that the mucoidy in all three mutants was due to the
increased expression of AlgUA61V. To do so, we introduced
pHERD20T-AlgUA61V into CF149. As predicted, CF149 carrying
pHERD20T-AlgUA61V displayed a mucoid phenotype (data not
shown). Furthermore, the absence of AlgUA61V in Figure 3B is
consistent with non-mucoidy of CF149 on PIA, which is probably
due to the reduced auto-regulatory activity of AlgUA61V [38].
Intramembrane Proteolysis has a Minimal Role in the
Regulation of Mucoidy in CF149
In wild type strain PAO1, AlgU can be sequestered by wild type
MucA, thereby preventing it from activating the alginate
biosynthetic operon [12,38,39]. Since all three mutants of
CF149 have an increased level of AlgUA61V, we next investigated
whether the wild type MucA can still exert an inhibitory effect on
AlgUA61V. The wild type mucA gene was transferred into these
mucoid strains: CF149 (+algU), CF149 (+sspA) and CF149 (2rpoD).
Over-expression of mucA suppressed mucoidy (Figure 4) suggesting
that the mucoidy of all three mutants is due to the activation of the
AlgU pathway. But the mutant MucA in CF149 has 128 amino
Figure 6. Mucoid mutants of P. aeruginosa display a reduced growth rate compared to the isogenic nonmucoid strain PAO1. The
growth curves were created by growth of PAO1 (nonmucoid), VE2 (mucoid) and PAO581 (mucoid) in PIB. The horizontal axis represents time in hrs,
while the vertical axis is the optical density at 600 nm. *, represents a significant difference compared to PAO1 (P,0.05).
doi:10.1371/journal.pone.0072329.g006
Figure 7. Schematic diagram for mucoid conversion in CF149
caused by competition between two sigma factors, RpoD and
AlgU. Stress or starvation can affect the expression of anti-s70 factors
resulting in a decrease in the activity of RpoD, which in turn increases
the chances for the alternative sigma factor AlgU to bind to the core
RNAP to initiate transcription for alginate biosynthesis. MucA is an anti-
sigma factor that has the ability to inhibit the activity of AlgU in alginate
production. Competition for RNAP between RpoD and AlgU can
determine which promoter is activated. RpoD binds to core RNAP to
promote the transcription of housekeeping genes, while AlgU binds to
core RNAP at the PalgD promoter to activate alginate production.
doi:10.1371/journal.pone.0072329.g007
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acid residues, and carries the intact trans-membrane domain of
MucA84–104. We also noticed that the promoter activity of PalgW in
CF149 (2rpoD) was increased compared to CF149 (Figure S3). To
test if intramembrane proteolysis has a role in cleaving the
periplasmic portion of MucA in CF149, we overexpressed
proteases algW, mucP, clpX, clpP and clpP2 and found this had no
effect on mucoid induction in CF149. Together, these results
suggest that these proteases have a minimal role in regulating the
mucoid conversion in CF149, or they may require a mechanism of
activation which is absent in CF149.
Competition between RpoD- and AlgU-dependent
Promoters in Mucoid and Non-mucoid Strains
Since the transcription from two promoters, PalgD and PssrA is
AlgU-dependent and RpoD-dependent, respectively, we cloned
these two promoters into a lacZ fusion vector (pLP170) and the
reporter b-galactosidase activity was measured [26]. As seen in
Figure 5A, alginate production in the mucoid strains VE2 and
PAO581 was higher than that in the non-mucoid strain PAO1.
Similarly, the promoter activity of PalgD also was higher in these
mucoid strains (Figure 5A). However, the promoter activity of PssrA
was inversely related to PalgD activity and alginate production
(Figure 5B), suggesting that the RpoD-dependent promoter was
less active in mucoid cells than in the isogenic non-mucoid cells.
We also measured the growth curve for mucoid and non mucoid
strains. As seen in Figure 6, the growth rate for mucoid strains was
reduced after 16 hrs growth for VE2 and PAO581 in comparison
with nonmoucid strain PAO1.
Discussion
Individuals with CF are thought to acquire initial colonization
of P. aeruginosa from environmental sources [9]. These early
colonizing strains display a non-mucoid phenotype with a wild-
type MucA [17]. Due to strong selective pressure in CF lungs,
mucoid mucA mutants eventually become a dominant population
[14,40]. However, secondary mutations that suppress alginate
overproduction have been reported [8,19]. One presumed
advantage with non-mucoid suppressors is the loss of mucoid
status is coupled with the presence of the flagella, which may
promote the colonization of new niches in the lungs [41,42].
Through screening a transposon library, we found that overex-
pression of sspA and CF149 algU, and reduced expression of rpoD,
are functionally equivalent in causing mucoid conversion in the
non-mucoid clinical isolate CF149. This mucoid phenotype can be
suppressed by overexpression of the anti-sigma factor MucA [12].
We propose that the mechanism for mucoid conversion mediated
by AlgU, SspA and RpoD in CF149 may be related to the
competition between sigma factors RpoD and AlgU for the core
RNAP binding site (Figure 7). Because of the differential binding
ability among sigma factors for core RNAP [43], s factor
competition exists within a cell at any given time [44]. We
investigated whether this competition is also present in CF149 and
CF149(2rpoD), by measuring the promoter activity of Palgw whose
activation depends on RpoN [45], and PalgD which is driven by
AlgU [11]. As seen in Figures 3C and S3, activities of both PalgD
and PalgW were increased in CF149 (2rpoD). Furthermore, the
mucoid suppression resulting from the overexpression of RpoD
can be attributed to the competition between two sigma factors
(Table 2). Table S2 illustrates that sigma factors besides RpoD can
also exert the same effect on mucoid suppression in mucA plus and
minus mucoid strains. Thus, any major shift in the intracellular
level of sigma factors can potentially affect mucoid conversion,
because the pool of core RNAP, which is made up of five different
subunits, must be in a limiting amount inside bacterial cells.
However, data in Figure S1 demonstrate that induction of FlgM,
which is the anti-sigma factor for RpoF responsible for the
transcription initiation of flagella biosynthesis [46], failed to induce
mucoidy in PAO1 and CF149. This may be due to the fact that
the impact on the pool of RNAP is somewhat different between a
minor sigma factor RpoF and a major sigma factor RpoD.
Therefore not all anti-sigma factors are functionally equal in terms
of alginate induction.
Anti-sigma factors are proteins that bind to cognate sigma
factors, thereby inhibiting their transcriptional activity [47]. The
E.coli protein Rsd associates specifically with s70 to inhibit the s70-
dependent transcription [48]. The P. aeruginosa transcriptional
regulator AlgQ/AlgR2, shares 55% identity at the amino acid
sequence level with Rsd [48], and has been proposed as an anti-
s70 factor that interacts with s70 to affect the transcriptional
activity of algD [49]. The T4 phage anti-s70 factor AsiA also has a
similar function as Rsd and AlgQ. Specifically, AsiA can regulate
the transcriptional activity of rpoD and other promoters
[37,50,51,52]. Although the amino acid sequence similarity is
low (,10%) between P. aeruginosa SspA to anti-s70 factors Rsd,
AsiA and AlgQ, the similarity at amino acid level between E. coli
SspA to P. aeruginosa SspA is higher than 50%. Hansen et al
reported that E. coli SspA is an RNAP-associated protein, and can
down-regulate expression from the s70-dependent promoters [53].
More importantly, E. coli SspA can functionally replace P.
aeruginosa anti-sigma factor AlgQ [35]. The sequence diversity in
anti-sigma factors suggests that they may have different binding
sites on RpoD [36]. Their inhibitory activity to the s70-driven
transcription is therefore different. Compared with the strong
inhibition of AsiA, Rsd shows only a modest effect on s70
transcription in vitro and in vivo [48,54,55]. This may explain why
overexpression of Rsd and AsiA can induce mucoidy in CF149
when the growth media are supplemented with 0.1% L-Ara, while
AlgQ-induced mucoidy in this strain requires a higher concentra-
tion of 0.5% L-Ara (Table 1). Also, compared with Rsd and AsiA,
AlgQ does not have the ability to significantly inhibit the growth of
E. coli in vivo [54].
In the current study, anti-s70 factors were found to have an
effect on mucoid induction in suppressed nonmucoid strain
CF149. This induction is not directly through the interaction
with the core RNAP, rather it is through the reduction of RpoD
activity. CF149 may be a rare alginate suppressor mutant. The
amino acid substitution in AlgUA61V in CF149 was mapped to the
conserved region of Sigma 70_r2 Superfamily [NCBI CDD
cl08419]. This region contains both the210 promoter recognition
helix and the primary core RNAP binding determinant. However,
the change from alanine to valine is of conservative nature (non-
polar to non-polar), which may explain why this mutation renders
AlgUA61V partially defective. Therefore, it is not surprising to see
that not all clinical isolates respond to the induction by anti-s70
factors in the same manner (Table 1). For example, CF4349 is not
inducible, even though it has a wild type AlgU and the mucA
genotype is the same as CF149. This suggests that there could be
another unknown suppressor mutation, which nullifies the effect of
anti-s70 induction in CF4349, or the mutation in CF149
AlgUA61V somehow amplifies the effect of anti-s70 induction.
Earlier work showed that the growth condition that promotes
the fast growth rate of P. aeruginosa PAO1 does not select for the
mucoid variants, but the condition that caused a slow growth rate
does [56]. In Salmonella, the expression of RpoE, the AlgU
homolog induced the stationary phase of growth (slow growth rate)
[57]. In the current study, overexpression of anti-RpoD factors can
induce mucoidy in CF149 and overexrpression of RpoD can
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inhibit mucoidy in all tested strains. Furthermore, there is a
competition between RpoD- and AlgU-dependent promoters
(Figure 5), and the growth rate of both mucoid strain VE2 and
PAO581 were slower than that of the isogenic nonmucoid strain
PAO1 (Figure 6). These data provide genetic evidence for the
sigma factor competiton in the regulation of alginate production
by P. aeruginosa.
Mucoid conversion in P. aeruginosa can be achieved through two
known mechanisms. Intra-membrane proteolysis acts as a primary
mechanism to initiate the degradation of MucA in P. aeruginosa
with wild type mucA [13]. Mutation of the mucA gene is another
mechanism to become mucoid and is prevalent in isolates from
chronic lung infections in CF [2]. In the current study, we showed
that a missense mutation in algU causes the loss of mucoidy in the
mucA mutant, but augmentation of anti-s70 factors such as SspA
leads to increased amounts of AlgU, causing mucoid conversion in
the AlgU-suppressed strain. Williams et al reported that carbon,
amino acid, nitrogen and phosphate starvation can induce the
expression of SspA [32], and Roychoudhury et al found that
starvation caused by nitrogen and phosphate limitation is one of
the signals leading to AlgQ-mediated activation of the algD
promoter in P. aeruginosa [58]. Therefore, stress signals may
activate the expression of anti-RpoD factors, thus causing mucoid
conversion in the suppressed strains.
In summary, we found three genes algU, sspA and rpoD that
regulate the conversion to mucoidy in the MucA-truncated, non-
mucoid P. aeruginosa strain CF149, which contains an AlgU-
suppressor mutation. Interestingly, our data indicate the missense
mutation in CF149 AlgU only reduces, but does not completely
abolish the function as the sigma factor that drives alginate
biosynthetic operon. The mechanism by which these genes cause
mucoidy may be due to competition between the sigma factors
AlgU and RpoD. Also, anti-s70 factors AsiA, Rsd, AlgQ and SspA
can induce mucoidy in strain CF149.
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Supporting Information
Figure S1 FlgM, an anti-sigma factor for RpoF, fails to
induce mucoidy in CF149 and PAO1. pHERD20T-flgM was
conjugated into CF149 and PAO1, respectively. Strains carrying
pHERD20T-flgM, pHERD20T-sspA, and pHERD20T were
incubated on PIA plates supplemented with 300 mg/ml carben-
icillin, 0.1% L-ara and incubated at 37uC for 24 hrs. Alginate was
harvested and measured as described in Materials and Methods. *,
represents a significant difference between each group (P,0.05).
(TIF)
Figure S2 The stability of over-expressed RpoD in P.
aeruginosa and E.coli. RpoD was expressed in P. aeruginosa
PAO581 (A) and E. coli TOP10 cells (B) carrying pHERD20T-
HA-rpoD-His under the induction with different concentration of
L-Ara. PAO581 carried pHERD20T-HA-rpoD-His was cultured
on PIA plates supplemented with 300 mg/ml carbenicllin and
different concentrations of L-Ara for 24 hrs and the cells were then
collected for cell lysis. TOP10 carried pHERD20T-HA-rpoD-His
was cultured on LB plates supplemented with 100 mg/ml
carbenicllin and L-Ara for 24 hours. Following sonication, 50 mg
protein of total cell lysate from each sample was used for SDS-
PAGE and Western blotting analysis. Lane 1: the protein
molecular mass standards; Lane 2: cells no L-Ara; Lane 3: cells
induced by adding 0.1% L-Ara; Lane 4: cells induced by adding
0.5% L-Ara; Lane 5: control with the empty vector.
(TIF)
Figure S3 Reduced expression of RpoD in
CF149(2rpoD) is correlated with increased promoter
activity of PalgW. RpoN dependent promoter pLP170-PalgW was
conjugated into CF149 and CF149 (2rpoD), respectively. The
Miller assay was used to detect the activation of PalgW in these
strains. *, represents the difference of the b-galactosidase activity
between these strains is significant (P,0.05).
(TIF)
Table S1 Strains and plasmids used in this study.
(DOC)
Table S2 Inhibitory effect of sigma factors RpoN, RpoS
and RpoF on P. aeruginosa mucoidy.
(DOC)
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